Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care
© 2022 The Authors..
OBJECTIVE: To evaluate the impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care at a National Cancer Institute-designated Comprehensive Cancer Center.
METHODS: We conducted a retrospective cohort study of patients referred for evaluation by a gynecologic oncologist at Washington University in St. Louis from October 2019 - February 2020 (pre-COVID-19), and April - August 2020 (COVID-19). The primary outcome, time from referral to evaluation by a gynecologic oncologist, was compared between the two time periods. Secondary outcomes included time from initial evaluation to treatment and delays/interruptions in care due to the pandemic. Sub-group analyses were performed on patients with a cancer diagnosis to evaluate the impact of COVID-19 on treatment decision making.
RESULTS: 884 patients were referred during the study period. Total referrals fell by 32% (526 to 358 patients, p < 0.001) and referrals for cancer fell by 18% (228 to 188 patients, p = 0.049). The pandemic did not impact time from referral to initial gynecologic oncology appointment overall (pre-COVID-19: 19.1 vs. COVID-19: 17.4 days, p = 0.315) or among patients with cancer (14.4 vs. 13.9 days, p = 0.662). Time from initial appointment to cancer treatment decreased by 9 days (34 days to 25 days, p = 0.001).
CONCLUSION: Referrals to gynecologic oncology decreased significantly during the early months of COVID-19. Though time from referral to evaluation was not impacted by the pandemic, time to treatment initiation decreased despite institutional changes related to COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
Gynecologic oncology reports - 39(2022) vom: 10. Feb., Seite 100928 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bruce, Shaina F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Access to care |
|---|
| Anmerkungen: |
Date Revised 30.04.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.gore.2022.100928 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335592783 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335592783 | ||
| 003 | DE-627 | ||
| 005 | 20231225230213.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.gore.2022.100928 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1118.xml |
| 035 | |a (DE-627)NLM335592783 | ||
| 035 | |a (NLM)35024405 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bruce, Shaina F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Authors. | ||
| 520 | |a OBJECTIVE: To evaluate the impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care at a National Cancer Institute-designated Comprehensive Cancer Center | ||
| 520 | |a METHODS: We conducted a retrospective cohort study of patients referred for evaluation by a gynecologic oncologist at Washington University in St. Louis from October 2019 - February 2020 (pre-COVID-19), and April - August 2020 (COVID-19). The primary outcome, time from referral to evaluation by a gynecologic oncologist, was compared between the two time periods. Secondary outcomes included time from initial evaluation to treatment and delays/interruptions in care due to the pandemic. Sub-group analyses were performed on patients with a cancer diagnosis to evaluate the impact of COVID-19 on treatment decision making | ||
| 520 | |a RESULTS: 884 patients were referred during the study period. Total referrals fell by 32% (526 to 358 patients, p < 0.001) and referrals for cancer fell by 18% (228 to 188 patients, p = 0.049). The pandemic did not impact time from referral to initial gynecologic oncology appointment overall (pre-COVID-19: 19.1 vs. COVID-19: 17.4 days, p = 0.315) or among patients with cancer (14.4 vs. 13.9 days, p = 0.662). Time from initial appointment to cancer treatment decreased by 9 days (34 days to 25 days, p = 0.001) | ||
| 520 | |a CONCLUSION: Referrals to gynecologic oncology decreased significantly during the early months of COVID-19. Though time from referral to evaluation was not impacted by the pandemic, time to treatment initiation decreased despite institutional changes related to COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Access to care | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Gynecologic oncology | |
| 650 | 4 | |a Pandemic | |
| 700 | 1 | |a Huysman, Bridget |e verfasserin |4 aut | |
| 700 | 1 | |a Bharucha, Jinai |e verfasserin |4 aut | |
| 700 | 1 | |a Massad, L Stewart |e verfasserin |4 aut | |
| 700 | 1 | |a Mullen, Mary M |e verfasserin |4 aut | |
| 700 | 1 | |a Hagemann, Andrea R |e verfasserin |4 aut | |
| 700 | 1 | |a Fuh, Katherine C |e verfasserin |4 aut | |
| 700 | 1 | |a McCourt, Carolyn K |e verfasserin |4 aut | |
| 700 | 1 | |a Thaker, Premal H |e verfasserin |4 aut | |
| 700 | 1 | |a Khabele, Dineo |e verfasserin |4 aut | |
| 700 | 1 | |a Powell, Matthew A |e verfasserin |4 aut | |
| 700 | 1 | |a Mutch, David G |e verfasserin |4 aut | |
| 700 | 1 | |a Kuroki, Lindsay M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gynecologic oncology reports |d 2014 |g 39(2022) vom: 10. Feb., Seite 100928 |w (DE-627)NLM248022156 |x 2352-5789 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2022 |g day:10 |g month:02 |g pages:100928 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gore.2022.100928 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2022 |b 10 |c 02 |h 100928 | ||